TEVA & Design — 1835940
Application number
1835940
Registration number
TMA1063767
Type(s)
Design
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Registered Owner
TEVA PHARMACEUTICAL INDUSTRIES LTD.
124 Dvora HaNevi'a
6944020 Tel Aviv-Jaffa
ISRAEL
Agent
OSLER, HOSKIN & HARCOURT LLP
Suite 320, World Exchange Plaza
100 Queen Street
Ottawa,
ONTARIO K1P1J9
Documents
Index headings
- TEVA
- V
Vienna information (Code & Description)
- 26.4.4
- Other irregular parallelograms, trapezia and quadrilaterals, quadrilaterals containing one or more rounded corners
- 26.4.9
- Several quadrilaterals juxtaposed, joined or intersecting
- A 26.4.24
- Quadrilaterals with dark surfaces or parts of surfaces
- 24.15.21
- Arrowheads -- Note: Not including arrowheads in the form of angles (26.3.23).
- 5.3.11
- Other leaves
- A 5.3.13
- Stylized leaves
- A 5.3.15
- Two to four leaves
- 25.5.3
- Backgrounds divided into two, diagonally
- 26.2.1
- Segments of circles or ellipses (except 26.2.7)
- 26.2.3
- Sectors of circles or ellipses (except 26.2.7)
- 26.2.5
- Joined or intersecting segments or sectors of circles or ellipses
- 26.11.2
- Two lines or bands
- A 26.11.12
- Curved lines or bands (except a 26.11.13)
- A 26.11.8
- Horizontal lines or bands
- 26.4.2
- Rectangles
- A 26.4.5
- One quadrilateral
- 26.4.12
- Quadrilaterals containing one or more other geometrical figures -- Note: Including quadrilaterals containing bent or straight lines (except 26.4.11).
- A 26.4.18
- Quadrilaterals containing one or more letters
- A 26.4.24
- Quadrilaterals with dark surfaces or parts of surfaces
- 29.1.3
- Green
- 29.1.6
- White, grey, silver
Colour claim
Colour is claimed as a feature of the trade-mark. The mark consists of a light green design that begins at the bottom left hand corner and rises up to the upper right hand corner. This light green continues in a straight light across the top. There are 2 darker green half circles at the bottom right hand corner that when they intersect make a dark green. In the dark green intersection at the bottom right hand corner is the word teva in lower case white letters. The v in the word teva is formed by 2 leaf shapes.
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease; Pharmaceutical preparations for the prevention and treatment of depression; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of cardiovascular and blood pressure disorders; Pharmaceutical preparations for the prevention and treatment of irritable bowel syndrome; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders, namely, Parkinson's disease and spinal muscular atrophy; Pharmaceutical preparations for the prevention and treatment of osteoporosis; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders, namely, carpal tunnel syndrome and connective tissue diseases; Pharmaceutical preparations for the prevention and treatment of digestive tract and gastrointestinal diseases and disorders; Pharmaceutical preparations for the prevention and treatment of dermatological diseases and disorders, namely, dermatitis, eczema and psoriasis; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of sexual dysfunction; Pharmaceutical preparations for the prevention and treatment of symptoms associated with uterine fibroids; Pharmaceutical preparations for the prevention and treatment of urinary incontinence and overactive bladder; Pharmaceutical preparations for the prevention and treatment of AIDS-related disorders; Pharmaceutical preparations that support, encourage and promote bone strength; Pharmaceutical preparations that support, encourage and promote bone health; Pharmaceutical preparations used in the treatment of bone disorders and bone diseases; Pharmaceutical preparations, namely injectable contraceptives; Pharmaceutical preparations, namely, contraceptive preparations; Pharmaceutical preparations, namely fertility enhancement preparations; Pharmaceutical preparations, namely, hormone replacement therapy preparations; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical agents for the treatment of the central nervous system, namely, for treating encephalitis, epilepsy, cerebral palsy, multiple sclerosis and Huntington's disease; Pharmaceutical agents for the treatment of circulatory systems, namely, for treating atherosclerosis, aneurysms and Raynaud's disease; Pharmaceutical agents affecting sensory organs, namely, for treating hearing loss and glaucoma; Pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases and incontinence.
Claims
- Priority Filing Date: February 28, 2017, Country or Office: UNITED STATES OF AMERICA, Application No. 87/352574 in association with the same kind of goods
- Proposed Use in CANADA
Recordals (known also as Footnotes)
Owner Address Change / Changement d'adresse du propriétaire DATE REGISTERED / DATE DE L'ENREGISTREMENT: 2022-02-28 COMMENTS / COMMENTAIRES: Voir Preuve au dossier/See evidence on File No. 2121983Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2017-05-04 | ||
| Created | 2017-05-05 | ||
| Formalized | 2017-05-10 | ||
| Search Recorded | 2018-04-20 | ||
| Examiner's First Report | 2018-04-20 | 2018-10-20 | |
| Correspondence Created | 2018-05-29 | 2018-11-29 | |
| Approval Notice Sent | 2019-01-08 | 2019-02-05 | |
| Rep for Service Changed | 2019-01-08 | From: 2520 To: 69 / Voir Preuve au dossier/See evidence on File No. 1839341 | |
| Agent Changed | 2019-01-08 | From: 2520 To: 69 / Voir Preuve au dossier/See evidence on File No. 1839341 | |
| Approved | 2019-02-28 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2019-03-20 | Vol.66 Issue 3360 | |
| Registration Pending | 2019-06-20 | ||
| Registration Fee Notice Sent | 2019-06-20 | 2019-12-20 | |
| Registered | 2019-11-20 | 2029-11-20 | |
| Amendment to Registration | 2022-02-28 | Owner Address Change / Voir Preuve au dossier/See evidence on File No. 2121983 |